Seal Rock Therapeutics, Inc. — Form D
Seal Rock Therapeutics, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2022-02-24. The offering totals $6.0M, of which $2.5M was reported sold. Industry: Other.
Offering
- Filed: 2022-02-24
- Form: D
- Accession: 0001911787-22-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $2.5M
- Remaining: $3.5M
- Investors: 16
- Date of first sale: 2022-01-28
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-434869
Issuer
- Name: Seal Rock Therapeutics, Inc.
- CIK: 0001911787
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: WEWORK C/O SEAL ROCK THERAPEUTICS, SEATTLE, WA, 98109
- Phone: 2062402143
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Neil McDonnell | Director | Burnaby, A1 |
| Artur Plonowski | Director | Seattle, WA |
| Keith Wycoff | Director | Seattle, WA |
| Neil McDonnell | Executive Officer | Burnaby, A1 |
| Artur Plonowski | Executive Officer | Seattle, WA |
| Neil McDonnell | Promoter | Burnaby, A1 |
| Artur Plonowski | Promoter | Seattle, WA |
More